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Developmental signalling: A careful balancing act
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Embryos of arthropods and chordates are patterned
along the dorso-ventral axis by a gradient of secreted
morphogens of the Bmp4/Dpp family. This gradient
now appears to be shaped by the opposing activities of
Bmp-sequestering proteins, on the one hand, and Bmp-
releasing metalloproteases, on the other.
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Bone morphogenetic proteins (Bmps) are secreted
proteins that were originally identified as regulators of
bone formation. Bmp1 is a member of the astacin family of
metalloproteases, while the other Bmps belong to the
transforming growth factor-β (TGF-β) superfamily of
growth factors. These proteins play important roles at
different stages in animal development, including deter-
mination of the dorso-ventral embryonic axis in both
arthropods and vertebrates [1]. Our understanding of the
regulation of Bmp signalling in dorso-ventral axis forma-
tion has progressed rapidly in the last three years. It now
appears that a crucial step in the regulation of Bmp
signalling occurs at the level of ligand availability, and
involves a cascade of extracellular regulators.
Bmps in dorso-ventral axis establishment
In lower vertebrates, Bmp2 and Bmp4 encode very similar
proteins expressed in the ventro-lateral territories of early
gastrulae. Their overexpression in the dorsal territories —
the ‘organiser’ — of Xenopus and fish embryos leads to
ventralisation of both mesoderm and ectoderm during
gastrulation. The effect of a deficiency of Bmp signalling
on dorso-ventral patterning in the mouse is difficult to
interpret, because this transduction pathway is required
very early during epiblast growth, a step that occurs before
the onset of expression of known dorso-ventral markers
[2]. In swirl mutant zebrafish, by contrast, inactivation of
Bmp2 leads to the down-regulation of Bmp4 and results in
a partial dorsalisation of affected embryos [3]. A similar
phenotype is observed following epigenetic inhibition of
Bmp signalling in Xenopus. 
These results point to a central role for Bmp signalling in
determining ventral identity in early vertebrate embryos.
The ventralising role of Bmps may not be limited to verte-
brates, as an ascidian Bmp, HrBmpb, has recently been
identified. Ectopic expression of HrBmpb ventralises the
ectoderm, resulting in an expansion of the epidermis at
the expense of neural tissue [4]. However, mesoderm
patterning is not affected in these embryos.
The Drosophila protein Decapentaplegic (Dpp) is highly
similar in sequence to Bmp2 and Bmp4, and its overex-
pression in Xenopus embryos also results in ventralisation.
In Drosophila, dpp is expressed in the dorsal territories,
where it is required for the differentiation of dorsal ecto-
dermal derivatives such as the amnioserosa. Ectopic
expression of dpp in more ventral ectodermal derivatives is
sufficient to dorsalise them, thus confirming the key role
of this factor in determining dorsal ectodermal identity in
Drosophila. The reversed roles of Bmp/Dpp in vertebrates
and arthropods supports Geoffroy St Hilaire’s proposition
that, during animal evolution, an inversion of the body
plan of these two phyla occurred [1]. 
Consistent with their being secreted polypeptides, the
actions of Bmp4 and Dpp are not restricted to the cells
that express them; rather, these signalling molecules can
act at long range [5,6]. Furthermore, ectopic expression of
different concentrations of these factors elicits different
cellular responses. For example, in Drosophila, low levels
of dpp expression permit development of ventral ecto-
derm, intermediate levels leads to dorsal epiderm, and
high levels to amnioserosa differentiation [7]. Taken
together, these results suggest that a gradient of Bmp/Dpp
activity plays a major part in patterning the dorso-ventral
axis in chordates and arthropods. 
Secreted negative regulators of Bmp signalling
The morphogenetic gradient in Bmp/Dpp activity could
correspond to a gradient of protein concentration.
Unfortunately, it has not so far been possible to quantify
in situ the local concentration of Bmp protein. However,
the identification of two orthologous proteins able to
sequester Bmp/Dpp, vertebrate Chordin (Chd) and
Drosophila Short gastrulation (Sog), suggests that the total
concentration of Bmp/Dpp protein may not be the most
crucial determinant of the activity gradient.
Chd and Sog are large secreted proteins which are
distantly related to thrombospondin and procollagens [1,8]
(Figure 1). Chd is expressed in the organiser in fish and
Xenopus embryos, while Sog is found in the ventral third of
the Drosophila embryo [1]. Loss of chd function ventralises
fish embryos [9], while loss of sog function dorsalises
Drosophila embryos [1]. Chd and Sog are functional homo-
logues, as ectopic expression of either dorsalises Xenopus
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embryos and ventralises Drosophila embryos [1]. In short,
chd and sog have a complementary pattern of expression
and an opposite activity to bmp4 and dpp, respectively.
Biochemical studies have shown that Chd can bind with
high affinity to Bmp4 homodimers (Kd = 3 × 10–10 M),
Bmp2 homodimers and Bmp4–Bmp7 heterodimers, but
not to activin or TGF-β1, two additional members of the
TGF-β superfamily [10]. Preincubation of Bmp4 with
Chd neutralises its biochemical activity, and prevents
receptor binding [10,11]. Furthermore, a rough measure
of Chd concentration within the organiser suggests that
this protein is present at sufficient levels to inactivate
endogenous Bmps [10]. Although similar experiments
have yet to be performed with Sog, the functional conser-
vation between these two proteins suggests that Sog too
acts by binding Bmps. Finally, genetic evidence indicates
that, while Sog is expressed in the lateral-ventral cells of
the Drosophila embryo, its domain of action includes the
most dorsal cells, suggesting that Sog can diffuse to act at
long range [12].
In addition to Chd and Sog, two other extracellular
inhibitors of Bmp signalling are secreted by the vertebrate
organiser — Noggin and follistatin. These two proteins
bear no sequence similarity to each other or to Chd/Sog.
Noggin is secreted as a dimer and binds Bmps
(Kd = 2 × 10–11 M) [13] but not TGF-β1, whereas follis-
tatin binds activin and is present in a complex with Bmp4
[14]. In spite of their affinity for Bmps, it is at present
unclear whether Noggin and follistatin are important for
axis formation. The model that emerges from all these
studies is that antagonistic molecules are secreted by
dorsal and ventral cells, leading to a graded distribution of
‘free’ Bmp proteins — molecules not complexed to an
antagonist — along the dorso-ventral axes of both verte-
brate and arthropod embryos (Figure 2).
Chd and Sog, but not Noggin, are cleaved by
Xolloid/Tolloid
In addition to Sog and Dpp, other factors act in Drosophila
to pattern the dorso-ventral axis. In particular, loss of
tolloid function, which acts upstream of sog [15], leads to
phenotypes similar to those of dpp mutants. Tolloid is a
large, glycosylated, secreted protein that is similar to
Bmp1. Tolloid contains a metalloprotease domain of the
astacin family as well as several EGF and CUB repeats,
which may mediate protein–protein interactions (Figure
1). Bmp1 was recently shown to be the carboxy-terminal
type I procollagen processing protein [16]. The weak simi-
larity between Sog and procollagens therefore suggested
that Tolloid may cleave Sog, thereby releasing active Dpp
from the complex. A search for vertebrate tolloid ortho-
logues led to the identification of Xenopus Xolloid and
zebrafish Z-tolloid, which are ubiquitously expressed at
the beginning of gastrulation [11,17]. 
Tolloid and its vertebrate orthologues, Xolloid and
Z-tolloid, do indeed act in the Bmp/Dpp pathway, by
antagonising the activity of Sog and Chd, but not that of
Noggin or follistatin [11,15,17]. Consistent with these
results, dorsal injection of Xolloid mRNA partially inter-
feres with organiser function [10]. Biochemical studies
have shown that Tolloid can cleave Sog at three positions;
Chordin is cleaved, and thereby inactivated, by Xolloid or
Z-tolloid at two of these three sites [11,15,17] (Figure 1).
It is not clear whether this difference reflects different
experimental conditions or a difference in structure or
function of the orthologues. The mechanisms of cleavage
also appear to differ. Xolloid can cleave Chd in the
absence of Bmp or within a Chd–Bmp complex, thereby
releasing free Bmp. Cleavage of Sog by Tolloid, in con-
trast, was enhanced by the presence of Bmp2 or Bmp4,
and Screw (another member of the Bmp family, related to
Bmp5) [15]. Again, it remains to be seen whether these
differences reflect real properties of Xolloid and Tolloid,
or whether they result from the different assay conditions
used in the two studies.
Finally, mutations of the protease domain of
Tolloid/Xolloid (Figure 1) give rise to ‘antimorphic’
proteins, which oppose the activity of the wild-type
Figure 1
The domain structures of Chd, Sog and several Tolloid-related
proteins. (a) Chd and Sog are large secreted proteins containing four
repeats (CR1–CR4, red boxes) distantly related to sequences in
procollagens [8]. The percentage of distributed sequence similarity of
Chd to Sog is indicated in brackets. The arrows indicate the
approximate sites of cleavage by Xolloid/Tolloid. (b) Tolloid-related
proteins have a prodomain (yellow), an astacin protease domain (blue),
two to five CUB repeats (C1–C5, purple; magenta boxes represent
imperfect repeats), and epidermal growth factor (EGF) repeats (green).
CUB and EGF repeats are thought to mediate protein–protein
interactions. In addition, spAN contains a cysteine-rich box (C, red)
and a threonine-rich domain (T, white). The percentage of sequence
identity of each family member to Tolloid is indicated in brackets.
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protein. Overexpression of one such protein in Xenopus
induces a strongly dorsalised phenotype, while overex-
pression of another, presumably weaker, dominant-nega-
tive protein in zebrafish only has a weak dorsalising effect
[11,17]. These latter results demonstrate that, like
Drosophila Tolloid, Xolloid and Z-tolloid play a role in
shaping the morphogenetic dorso-ventral gradient of Bmp
activity (Figure 2).
Regulation of Xolloid/Tolloid activity and specificity 
As with other astacin-like proteases, Tolloid, which has no
autocatalytic activity, requires amino-terminal cleavage to
become active [15] (Figure 1). The protease that catalyses
this step has not yet been identified but, as most Tolloid
protein is found as an unprocessed precursor in the
embryo, its activity must be tightly regulated [15].
Bmp/Dpp activity is thus regulated by a cascade of
extracellular proteases. The identification of the upstream
proteases will be of great interest.
The molecular basis of the specificity of Xolloid/Tolloid
proteases also needs clarification. Although Tolloid/Xolloid
cleaves Chd/Sog, overexpression of the closely related
Drosophila protein Tolloidr-1/Tolkin (53% sequence iden-
tity with Tolloid; see Figure 1) fails to rescue tolloid
mutants, suggesting that this protein is unable to cleave
Sog [18]. In contrast, overexpression in Xenopus embryos of
the more distantly related sea urchin protein SpAN (27%
identity with Tolloid) interferes with Bmp signalling and
leads to complete ventralisation [19] Even more surprising,
ventral overexpression of Xenopus Xtld (76% identity with
Xolloid) dorsalises the embryo, an effect similar to that
caused by the overexpression of a dominant-negative
mutant form of Xolloid [20]. 
One can envisage at least three levels at which the
specificity of Tolloid/Bmp1/SpAN family proteins could be
regulated. First, the proteases needed to activate them
may be different. As the putative cleavage sites in Tolkin
and Xtld have different sequences from those of SpAN and
Xolloid/Tolloid, the former proteins may not be processed
in the embryo; they may act like natural Xolloid/Tolloid
antagonists. Second, the protease domains may have differ-
ent specificities. This, however, cannot fully account for
the activity of the Tolloid-like proteins, as truncated forms
of Tolloid or Z-tolloid that retain an intact protease domain
fail to cleave their substrate. Third, the generation of dom-
inant-negative forms of the proteins by inactivating their
protease domains suggests that the CUB/EGF
protein–protein interaction domains have a crucial role in
substrate recognition. A series of domain-swapping experi-
ments between the different family members will help us
understand the basis of cleavage specificity.
Finally, as Bmp and TGF-β family proteins have been
implicated in a number of important physiological and
pathological processes, it is likely that several groups will
test whether diffusible proteins such as Noggin of Chd/Sog
can interfere with, or even correct, these processes and
perhaps eventually lead to new therapeutic approaches.
Figure 2
A model of how a morphogenetic Bmp/Dpp
gradient could be established. The bmp/dpp
genes are expressed uniformly along the
dorso-ventral axis, except in the dorsal
marginal zone of Xenopus and the ventral
epidermis of Drosophila; the encoded proteins
(blue), which are secreted into the extracellular
space, are thought to be present at uniform
level throughout their expression domains.
Expression of chd/sog is restricted to the
dorsal marginal zone of Xenopus and to the
ventral territories of Drosophila. The Bmp/Dpp
gradient is established through the opposing
activities of Chd/Sog (yellow) and
Xolloid/Tolloid (red). Chd/Sog directly binds
Bmp/Dpp, preventing the latter from
associating with its receptor, while
Xolloid/Tolloid cleaves Chd/Sog–Bmp/Dpp
complexes, releasing active Bmp/Dpp. Xolloid
also cleaves free Chd, preventing it from
binding Bmps. These opposing activities may
fine-tune the level of available Bmp/Dpp along
the dorso-ventral axis. Thus, in this model, cells
located at (1) receive more free Bmp/Dpp
than cells in (2) or (3), and cells secreting
antagonistic Chd/Sog (4) are refractory to
Bmp/Dpp signalling. This model assumes that
Chd/Sog can diffuse along the dorso-ventral
axis, which has not been directly demonstrated
to date. It is also worth noting that Bmp–Chd
antagonism is potentiated at the transcriptional
level by a negative regulatory loop between
chd and bmp4/bmp2 [9].
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